Home | Technology

Technology

Dementia drug rejected by TGA

The Therapeutic Goods Administration (TGA) has decided not to register Alzheimer's drug lecanemab (LEQEMBI) on the basis that "the demonstrated efficacy did not outweigh the safety risks associated with the use of this medicine." Lecanemab is an antibody infusion therapy ...

More »